ESR1 and breast cancer: On the other hand, overall survival is significantly impaired in ERα-positive patients who show high DOT1L expression (Figure 1c), which suggests that a combined activity of both these factors might lead to a more aggressive behavior of OC cells, by possibly acting on common targets, as demonstrated previously in breast cancer [18].